Stock News

Trading Commences on Major Canadian Exchange, Increased Visibility to Investors as the Company Enters Water Treatment Market with New Technologies Corsicana, Texas–(Newsfile Corp. – November 12, 2024) – 8:07 AM ET Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) (“Birchtech” or the “Company”), a leading environmental technologies firm, announces today that it has received final approval from…

Coles Supermarkets Introduces AI-Powered Smart Trolleys to Melbourne Joining Forces with Instacart to Revolutionize Shopping Experience MELBOURNE, Australia – Nov. 12, 2024 – Coles Supermarkets, a household name in Australia, is set to transform the way customers shop with the introduction of Caper Carts, Instacart’s AI-powered smart trolleys. This innovative partnership between Coles Supermarkets and…

Exciting News in Cancer Treatment Company Leading the Way in AML Trials Recently, Moleculin Biotech, Inc. announced that it is on track to treat the first subject in its pivotal Phase 3 clinical trial in early 2025. This trial, known as the “MIRACLE” trial, is designed to potentially accelerate the approval of Annamycin in combination…

Charmingly Eccentric Document Intelligence and ChatIQ Enhance S&P Capital IQ Pro for Maximum Reader Engagement Exciting news has just been announced by S&P Global, a leading financial information and analytics company. S&P Global has introduced groundbreaking generative-AI (GenAI) enhancements to its S&P Capital IQ Pro platform. These enhancements include the innovative technologies of Document Intelligence…

The Future of Medical Technology: A Breakthrough in Trials Vancouver, Kelowna, and Delta, British Columbia–(Newsfile Corp. – November 12, 2024) – Investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future of medical technology as first patients are enrolled in potential breakthrough trials, featuring Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic…

Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million – $43 million ZYNRELEF® (bupivacaine and meloxicam) extended-release solution Vial Access Needle (“VAN”) approved in September and on track for Q4 2024 launch CMS Final Rule Non-Opioid Policy for Pain Relief includes ZYNRELEF as…

EchoStar’s Strategic Transactions Positioning It for Nationwide Open RAN 5G Network Enhancement Highlighting the Value of EchoStar’s Spectrum Assets EchoStar’s recent transactions underscore the tremendous value of its spectrum assets, providing a sturdy platform for the company to accelerate the deployment of a nationwide wireless service. This move is aimed at intensifying competition with existing…

FreightCar America Reports Strong Third Quarter Results Overview FreightCar America, a leading manufacturer and supplier of railroad freight cars, has delivered impressive results for the third quarter of 2024. The company reported a revenue growth of 83% year-over-year, with a strong gross margin and increased adjusted EBITDA guidance. Third Quarter 2024 Highlights During the third…